Coronavirus India lockdown day 238 live updates | India records 45,576 infections, 585 fatalities

India’s COVID-19 caseload rose to 89.58 lakh with fresh 45,576 infections, while the number of people who have recuperated from the disease surged to over 83.83 lakh pushing the national recovery rate to 93.58%, according to data updated by the Union Health Ministry on Thursday.

You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.

Here are the updates:


New York City schools to close again as city fights coronavirus

New York City is shuttering schools to try to stop the renewed spread of the coronavirus , Mayor Bill de Blasio said Wednesday in a painful about-face for one of the first big U.S. school systems to bring students back to classrooms this fall.

The nation’s largest public school system will halt in-person learning from Thursday, the Mayor and Schools Chancellor said.



Cipla, MultiG ink deal to supply antibody test kit

Drug major Cipla on Wednesday said it had signed a licensing agreement with Belgium-based MultiG for distribution of their COVID-19 rapid antibody test kit, Covi-G, across most emerging markets and Europe. This agreement is part of Cipla’s efforts to enhance global access to life-saving treatments and diagnostic infrastructure for patients in need, the company said in a regulatory filing.

Cipla said MultiG rapid antibody kit has been commercialised in over 20 countries already, with sensitivity and specificity exceeding 92%.


Jammu and Kashmir

People above 70 years, women most affected by COVID-19 in J&K: study

The population above 70 years and women are the most affected by theCOVID-19 pandemic as Kashmir has shown prevalence of the virus-induced antibodies among two out of five persons in its 10 districts at 38.8%, according to a study released on Wednesday.

“The study indicates that there has been a widespread transmission of COVID-19 infection in the general population. There are apprehensions that the majority of the unaffected population may also contract the infection if standard operating procedures are not followed,” Dr. Salim Khan, head of the department, Community Medicine, Government Medical College, Srinagar, said.

According to the sero-prevalence study, COVID-19 specific antibodies were found prevalent among 38.8% samples in the population selected from l0 districts of the Kashmir Valley.


Andhra Pradesh

AP stays below 2,000 cases for 10 days in a row

The State reported fewer than 2,000 new coronavirus infections in 24 hours ending Wednesday morning, for the tenth day in a row. With the new cases, the cumulative tally went up to 8,57,395. The death toll increased to 6,899, with nine new deaths reported in the past day. The death rate remains at 0.80%.

As many as 1,236 new infections were detected as 69,618 samples were tested, registering single-day positivity rate of 1.78%. The overall positivity rate for 93.3 lakh tests came down to 9.19%.


Disclaimer: This post has not been edited by our staff and is published from a syndicated feed. The Original Source of this post can be found at Source link


Please enter your comment!
Please enter your name here


Sunrise Hospital loses COVID treatment permit, Anil Neuro fined ₹2 lakh

The former was ‘overcharging’ patients while the latter did not have permission The district administration imposed a temporary ban...

TTD decentralises cottage allotment system

In a pilgrim-friendly move, the Tirumala Tirupati Devasthanams (TTD) on Monday simplified the allotment procedure of cottages and guesthouses to the devotees who have...

U.S. will boost ‘Do Not Travel’ advisories to 80% of world

The U.S. State Department said on Monday it will boost its “Do Not Travel” guidance to about 80% of countries worldwide, citing “unprecedented...

Newly-elected AMC corporator passes away

The 17th ward corporator, Chintakunta Padmavathamma(58), died on Monday morning after undergoing treatment at a hospital in Bengaluru for the past four days. Padmavathamma,...

More Articles